• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Comparison of iv lignocane and iv labetalol for the attenuation of hemodynamic response to laryngoscopy and endotracheal intubation

    Dr. Kota Ramya, Dr. PB Banerjee

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 3043-3049

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Laryngoscopy and endotracheal intubation result in pressor and sympathoadrenal responses. Certain agents such as Lignocaine and Labetalol can be given to prevent these hemodynamic changes prior to intubation.
Materials and Methods: 60 patients of ASA grade I, scheduled for various surgeries under general anaesthesia were divided into 2 Groups. Patients in Group A were given 2% Inj. Lignocaine hydrochloride (preservative free) intravenously at 1.5mg/kg over 10 seconds, 90 seconds before laryngoscopy. Patients in Group B were administered 0.5 mg/kg Inj. Labetalol IV, 10 minutes before intubation. Laryngoscopy and endotracheal intubation were performed after induction. Heart rate, systolic, diastolic and the mean arterial blood pressure were recorded before induction, after induction, during intubation and at 1, 3 and 5 minutes post intubation.
Results: Heart rate, systolic and diastolic blood pressures and the mean arterial pressures were significantly lower in the Labetalol group when compared to the Lignocaine group, with the mean arterial pressure and the heart rate attaining the basal value in the Labetalol group after 5 minutes of intubation, while it was still higher in the Lignocaine group.
Conclusion: Labetalol is a better drug for the attenuation of the hemodynamic changes that take place during intubation compared to Lignocaine.
Keywords:
    Labetalol lignocaine hemodynamic changes Laryngoscopy endotracheal intubation
  • PDF (232 K)
  • XML
(2023). Comparison of iv lignocane and iv labetalol for the attenuation of hemodynamic response to laryngoscopy and endotracheal intubation. European Journal of Molecular & Clinical Medicine, 9(2), 3043-3049.
Dr. Kota Ramya, Dr. PB Banerjee. "Comparison of iv lignocane and iv labetalol for the attenuation of hemodynamic response to laryngoscopy and endotracheal intubation". European Journal of Molecular & Clinical Medicine, 9, 2, 2023, 3043-3049.
(2023). 'Comparison of iv lignocane and iv labetalol for the attenuation of hemodynamic response to laryngoscopy and endotracheal intubation', European Journal of Molecular & Clinical Medicine, 9(2), pp. 3043-3049.
Comparison of iv lignocane and iv labetalol for the attenuation of hemodynamic response to laryngoscopy and endotracheal intubation. European Journal of Molecular & Clinical Medicine, 2023; 9(2): 3043-3049.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 7
  • PDF Download: 11
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus